Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

被引:0
|
作者
Nakamura, Minoru
Kondo, Hisayoshi
Mori, Tsuyoshi
Komori, Atsumasa
Matsuyama, Mutsumi
Ito, Masahiro
Daikoku, Manabu
Yatsuhashi, Hiroshi
Takezaki, Eiichi
Masaki, Naohiko
Sugi, Kazuhiro
Adachi, Hiroshi
Sakai, Norihiro
Watanabe, Yukio
Saoshiro, Takeo
Honda, Koichi
Harada, Hideharu
Hayashi, Shigeki
Sando, Takehiro
Masumoto, Akihide
Shimada, Masaaki
Komatsu, Tatsuji
Shums, Zakera
Norman, Gary L.
Ishibashi, Hiromi
机构
[1] Natl NHO Nagasaki Med Ctr, Clin Res Ctr, Omura, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hepatol, Omura, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Nagasaki 852, Japan
[4] NHO Study Grp Liver Dis Japan, Omura, Japan
[5] INOVA Diagnost, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1180
引用
收藏
页码:629A / 629A
页数:1
相关论文
共 50 条
  • [31] Anti-sp100 antibodies in primary biliary cirrhosis
    Rigopoulou, EI
    Dalekos, GN
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (04) : 406 - 407
  • [32] Anti-Saccharomyces cerevisiae Antibodies in Primary Biliary Cirrhosis
    Wahiba Sakly
    Moncef Jeddi
    Ibtissem Ghedira
    Digestive Diseases and Sciences, 2008, 53 : 1983 - 1987
  • [33] Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis
    Sakly, Wahiba
    Jeddi, Moncef
    Ghedira, Ibtissem
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) : 1983 - 1987
  • [34] ANTI-MITOCHONDRIAL ANTIBODIES AND FATIGUE IN PRIMARY BILIARY CIRRHOSIS
    Poyner, Elizabeth F.
    Newton, Julia L.
    Jones, David E.
    HEPATOLOGY, 2008, 48 (04) : 600A - 600A
  • [35] Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis
    Haldar, Debashis
    Janmohamed, Ashnila
    Plant, Tim
    Davidson, Matthew
    Norman, Hannah
    Russell, Emily
    Serevina, Olivia
    Chung, Kenneth
    Qamar, Kashif
    Gunson, Bridget
    Hansen, Bettina
    Richter, Alex
    Trivedi, Palak J.
    Hirschfield, Gideon M.
    LIVER INTERNATIONAL, 2021, 41 (03) : 535 - 544
  • [36] Antibodies to gp210 and Understanding Risk in Patients with Primary Biliary Cholangitis.
    Haldar, Debashis
    Janmohamed, Ashnila
    Plant, Tim
    Davidson, Matthew
    Norman, Hannah
    Russell, Emily
    Serevina, Olivia
    Chung, Kenneth
    Qamar, Kashif
    Gunson, Bridget
    Richter, Alex
    Hirschfield, Gideon
    HEPATOLOGY, 2018, 68 : 1096A - 1096A
  • [37] ANTI-CHLAMYDIA PNEUMONIAE ANTIBODIES IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS
    Bauer, Alicja
    Habior, Andrzej
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S581 - S581
  • [38] ANTI-ACETYLCHOLINE RECEPTOR ANTIBODIES IN PRIMARY BILIARY-CIRRHOSIS
    SUNDEWALL, AC
    LEFVERT, AK
    OLSSON, R
    ACTA MEDICA SCANDINAVICA, 1985, 217 (05): : 519 - 525
  • [39] Serum anti-mitochondrial antibodies and fatigue in primary biliary cirrhosis
    Newton, Julia
    Poyner, Elizabeth
    Jones, David E. J.
    LIVER INTERNATIONAL, 2009, 29 (08) : 1285 - 1286
  • [40] The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis
    Kampolis, C.
    Plastiras, S. C.
    Vlachoyiannopoulos, P. G.
    Moyssakis, I.
    Tzelepis, G. E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 (04) : 278 - 283